Finance

Lists
Why is KNSA down 7,28%?
Dive Deeper
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
89,12 USD
-7,28%
(-7,00) 1D
5-ноя., 14:42:44 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KNSA...
Open
95,49 USD
High
96,99 USD
Low
88,40 USD
Mkt. cap
7,02 млд
Avg. vol.
813,28 миң
Volume
495,74 миң
P/E ratio
68,02
52-wk high
98,48 USD
52-wk low
37,02 USD
EPS
1,31 USD
Beta
0,07
Shares outstanding
48,84 млн
No. of employees
366
Open
95,49 USD
High
96,99 USD
Low
88,40 USD
Mkt. cap
7,02 млд
Avg. vol.
813,28 миң
Volume
495,74 миң
P/E ratio
68,02
52-wk high
98,48 USD
52-wk low
37,02 USD
EPS
1,31 USD
Beta
0,07
Shares outstanding
48,84 млн
No. of employees
366
News stories
From web sources and news partners
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
HeadquartersЛондон, Ингленд, Улуу Британия
SectorHealth Care
Industry-
Websitekiniksa.com
Analyst ratings
Based on 5 analysts giving stock ratings to KNSA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for KNSA in the last 3 months.
Highest
Current 89,12 USD
122,00 USD (+36,89%)
Average
106,20 USD (+19,17%)
Lowest
98,00 USD (+9,96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Buy
Reiterated
122,00 USD
+36,9%
10/30/2026
Edward Nash
Canaccord Genuity
Buy
Maintained
98,00 USD
+10%
10/28/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
110,00 USD
+23,4%
10/28/2026
Paul Choi
Goldman Sachs
Buy
Reiterated
101,00 USD
+13,3%
10/27/2026
Geoff Meacham
Citi
Buy
Maintained
100,00 USD
+12,2%
10/15/2026
David Nierengarten
Wedbush
Buy
Reiterated
99,00 USD
+11,1%
07/28/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Reiterated
87,00 USD
-2,4%
07/29/2026
Nicholas Lorusso
TD Cowen
Buy
Reiterated
95,00 USD
+6,6%
07/28/2026
Roger Song
Jefferies
Buy
Maintained
71,00 USD
-20,3%
04/28/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
53,00 USD
-40,5%
04/14/2026
Last report
2026-ж., 27-окт.
Fiscal period
Q3 2026
0,56 USD / 0,31 USD
+79,20%beat
Revenue / Est. (USD)
285,97 млн / 260,61 млн
+9,73%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
202,13 млн
214,27 млн
243,60 млн
285,97 млн
Cost of goods sold
90,98 млн
96,37 млн
111,64 млн
133,59 млн
Cost of revenue
90,98 млн
96,37 млн
111,64 млн
133,59 млн
Research and development expenses
34,61 млн
27,48 млн
40,90 млн
32,79 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,78 млн
61,15 млн
63,87 млн
65,36 млн
Operating expense
91,38 млн
88,63 млн
104,76 млн
98,15 млн
Total operating expenses
182,36 млн
185,00 млн
216,41 млн
231,73 млн
Operating income
19,77 млн
29,27 млн
27,19 млн
54,24 млн
Other non operating income
3,50 млн
3,41 млн
3,95 млн
-169,00 миң
EBT including unusual items
23,27 млн
32,68 млн
31,14 млн
59,06 млн
EBT excluding unusual items
23,27 млн
32,68 млн
31,14 млн
59,06 млн
Income tax expense
9,07 млн
10,09 млн
5,71 млн
11,71 млн
Effective tax rate
38,98%
30,87%
18,34%
19,83%
Other operating expenses
-
-
-
-
Net income
14,20 млн
22,59 млн
25,43 млн
47,34 млн
Net profit margin
7,02%
10,54%
10,44%
16,56%
Earnings per share
0,17
0,27
0,30
0,56
Interest and investment income
-
-
-
4,99 млн
Interest expense
-
-
-
-
Net interest expenses
-
-
-
4,99 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
20,24 млн
29,74 млн
27,67 млн
54,73 млн
Gain or loss from assets sale
-53,00 миң
-54,00 миң
22,00 миң
8,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору